Outcome of Board Meeting

Compliances/Letter/2 Date: September 15, 2026 BSE Limited, National Stock Exchange of India Limited, The listing department, The listing department, P.J. Towers, Dalal Street, Exchange Plaza, Sandra Kurla Complex, Mumbai - 400001. Sandra (East), Mumbai- 400051. Scrip Code: 532904 Symbol: SUPREMEINF Subject: Outcome of the Meeting of the Board of Directors held on Tuesday, September 15, 2026. In terms of Regulation 30 of SEBI Listing Regulations, we wish to inform that Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors ("Board"), at its meeting held today, has, inter-alia considered and approved appointment of a Dr. Prabhakant (DIN: 11640370) as an Additional Director, designated as Non-Executive Independent Director on the Board of the Company, with effect from the conclusion of business hours on September 15, 2026, subject to approval of the shareholders of the company. We hereby confirm that Dr. Prabhakant, who has been appointed as an Additional Non-Executive Independent Director, is not debarred from holding the office of director by virtue of any SEBI order or any other such authority. The brief profile of Dr. Prabhakant is enclosed as Annexure A to this letter. The Board Meeting commenced at 4:45 pm and concluded at 4:50 p.m. Request you to take the same on record. Thanking you, For Supreme Infrastructure India Limited ( ·s~ ~rth Jain Chief Financial Officer SUPREME INFRASTRUCTURE INDIA LIMITED Supreme House, Plot No.94/C, Pratap Gad, 1.1.T. Main Gate, Powai, Mumbai-400 076 Tel : + 91 22 6128 9700, Mob-+ 91 8425833332 Fax : + 91 22 6128 9711, website :www.supremeinfra.com CIN: L 74999MH1983PLC029752 AnnexureA Sr. Particulars Details 1. Dr. Prabhakant Dr. Prabhakant 2. Reason for change Appointed as Additional Non-Executive Independent Director of the Company. 3. Date of appointment September 15, 2026 4. Brief profile Enclosed as Annexure A-1 5. Disclosure of relationships Dr. Prabhakant is not related to any director of between directors (in case of the Company. appointment of a director) Annexure A-1 Dr. Prabhakant (IRS), Chief Commissioner of Income Tax (Retd.) The addition of Dr. Prabhakant to the Board brings more than three decades of senior level regulatory, taxation, enforcement and administrative experience. His presence is expected to strengthen governance, improve regulatory preparedness, enhance risk oversight and add greater depth to strategic decision-making-further positioning the Company for disciplined, transparent and sustainable long-term growth. • Strengthened Corporate Governance & Compliance: The Company Management will gain additional inputs from the vast experience that Dr. Prabhakant brings through his regulatory dealings and continued contributions in taxation and enforcement matters, and this is expected to strengthen the Company's governance, transparency, accountability, and compliance framework. • 30+ Years of Institutional & Regulatory Expertise: His distinguished career across Income Tax, International Taxation, the Enforcement Directorate and senior administrative roles brings exceptional institutional knowledge and regulatory insight to Board-level deliberations, enabling more informed and prudent decision-making. • Strategic & Transformation-Led Perspective: His experience in policy formulation, digital tax administration, TDS computerization and TIN Phase I, together with his institution-building leadership at NYKS, can provide valuable perspectives on technology, process efficiency, organizational transformation and sustainable business growth. • Stronger Institutional Credibility & Long-Term Value Creation: His association is expected to enhance the Company's institutional profile, strengthen Board oversight and stakeholder confidence, and support disciplined strategic execution aimed at sustainable growth, stronger governance and long-term shareholder value creation.